Loading
Latest filing published 26 Sept 2013 for KV PHARMACEUTICAL CO /DE/.
No signal scores available.
David S. Hermelin is a declared insider of KV Pharmaceutical Co /DE/, with filings sourced from SEC (Form 4). Between 3 April 2006 and 16 September 2013, the trades on record add up to 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 26 September 2013: a transaction, in KV Pharmaceutical Co /DE/. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 10 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations